Work

Epidermal growth factor receptor in pancreatic beta cell mass regulation

Year: 2014
Type: dissertation
Abstract: Pancreatic beta cells produce and secrete insulin into circulation in order to control blood glucose levels. The amount of beta cells is tightly controlled throughout life. If the number or function of beta cells is compromised, glucoregulation does not function properly, leading to dysglycemia. In the case of type 1 diabetes, beta cells are selectively targeted by an autoimmune attack, and die through apoptosis. Type 2 diabetes develops due to peripheral insulin resistance, combined with pancreatic beta cell failure. Individuals with type 2 diabetes show a reduced beta cell mass and increased beta cell apoptosis, leading to a relative lack of insulin. Treatments that replenish beta cell mass in diabetic patients could enable restoration of normal glycemic control and represent a potentially curative therapy. A better understanding of the factors that regulate or protect beta cell mass and function is important for the development of new treatments for all forms of diabetes. The major aim of the present study was to elucidate the role of epidermal growth factor receptor (EGFR) in beta cell mass regulation and protection against diabetogenic insults. Two mouse models were generated for these studies: one with downregulated EGFR signaling in beta cells through expression of a dominant-negative EGFR mutation, and the other with increased EGFR signaling through expression of constitutively active EGFR in beta cells. In the dominant-negative EGFR mouse model beta cell mass failed to expand during obesity and gestation, suggesting that EGFR signaling is crucial in beta cell mass regulation during these metabolic challenges. Subsequent mechanistic studies identified survivin as a candidate EGFR-regulated target mediating beta cell mass expansion during gestation. EGFR activation during the neonatal period led to increased beta cell proliferation and mass. In contrast, in adults EGFR activation had only a minor effect on beta cell proliferation and mass. Furthermore, EGFR activation protected beta cells against apoptosis in vivo during diabetogenic insults and in vitro when challenged with inflammatory cytokines. Mechanistic studies suggested that EGFR signaling protected isolated islets from cytokine-mediated beta cell death by repressing the proapoptotic protein Bim. In conclusion, EGFR signaling appears to be important in beta cell mass expansion during metabolic challenges. The observation that EGFR stimulation protects against experimental diabetes suggests that enhancing EGFR signaling could prevent or revert beta cell loss in diabetes.
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W1603986013
Cites:
Cited by:
Related to: 10